Riskpilot← Back to searchSign inGet full accessDEEPX HEALTH AS
ASActiveOrg 984648758Vestre Strømkaien 7, 5008 BergenWholesale of pharmaceutical and medical goods · NACE 4646Est. 20023 employees
Revenue 2024
NOK 793K
+501% vs 2023
EBITDA margin
-191.9%
-44% vs 2023
Equity ratio
87.9%
Financial strength
Net profit 2024
NOK 67,9M
+255% vs 2023
| Revenue | NOK 793K | +501% |
| EBITDA | NOK -1,5M | -44% |
| Net profit | NOK 67,9M | +255% |
| Total assets | NOK 160,7M | +113% |
| Equity | NOK 141,3M | +142% |
| Employees | 3 | — |
Legal name
DEEPX HEALTH AS
Org number
984648758
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. juni 2002
Share capital
NOK 6 128 960
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder alene.
Company purpose
Utvikling og salg/lisensiering av medisinske produkter og tjenester, og hva dermed står i naturlig forbindelse, herunder deltakelse i andre selskaper med lignende formål. Selskapet kan også investere i verdipapirer, enten i form av oppfølgingsinvesteringer i selskap man allerede har investert i, eller som ledd i andre strategiske investeringer.
Address
Vestre Strømkaien 7, 5008 Bergen
Phone
+4790163153
Email
christian.horn@deepxhealth.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 715 | 313 | 819 | 132 | 793 |
| Staff expenses | −2 788 | −2 482 | −1 906 | −815 | −1 393 |
| EBITDA | −2 419 | −3 356 | −3 698 | −1 060 | −1 522 |
| Depreciation & amort. | −4 | −15 | −24 | −20 | −10 |
| EBIT | −2 423 | −3 370 | −3 721 | −1 080 | −1 532 |
| Net financials | −856 | −33 | 22 012 | −42 640 | 69 481 |
| Profit before tax | −3 279 | −3 403 | 18 290 | −43 720 | 67 949 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 279 | −3 403 | 18 290 | −43 720 | 67 949 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 72 566 | 91 582 | 125 050 | 75 581 | 160 668 |
| Equity | 64 260 | 85 862 | 113 998 | 58 486 | 141 279 |
| Long-term debt | 0 | 0 | 10 170 | 16 819 | 19 000 |
| Short-term debt | 8 305 | 5 720 | 883 | 277 | 389 |
| Total debt | 8 305 | 5 720 | 11 053 | 17 095 | 19 389 |
EBITDA margin
-191.9%
This company
15.8%
Market median
-1315% vs market
20202024
Equity ratio
87.9%
This company
38.2%
Market median
+130% vs market
20202024
Return on equity
48.1%
This company
18.4%
Market median
+161% vs market
20202024
Net profit margin
8569.3%
This company
8.1%
Market median
+105694% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CH Chief Executive Officer | Chief Executive Officer | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2019 | |
| Board of Directors | 2019 | |
| Former (2) | ||
| Board of Directors | 2019 – 2025 | |
| Board of Directors | 2019 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 26.59% | 26.59% | 2024 | |
| Company | 16.64% | 16.64% | 2024 | |
| Company | 13.71% | 13.71% | 2024 | |
| Company | 10.19% | 10.19% | 2024 | |
| Company | 7.76% | 7.76% | 2024 | |
| Company | 6.27% | 6.27% | 2024 | |
| Company | 5.5% | 5.5% | 2022 | |
| Individual | 3.61% | 3.61% | 2022 | |
| Company | 3.11% | 3.11% | 2022 | |
| Company | 2.61% | 2.61% | 2024 | |
| Company | 2.28% | 2.28% | 2024 | |
| Company | 2.12% | 2.12% | 2022 | |
| Individual | 1.91% | 1.91% | 2022 | |
| Individual | 1.8% | 1.8% | 2022 | |
| Individual | 1.66% | 1.66% | 2022 | |
| Company | 1.36% | 1.36% | 2024 | |
| Company | 1.36% | 1.36% | 2022 | |
| Company | 1.31% | 1.31% | 2024 | |
| Individual | 1.31% | 1.31% | 2024 | |
| Company | 1.17% | 1.17% | 2024 | |
| Company | 1.12% | 1.12% | 2024 | |
| Individual | 1.02% | 1.02% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Consolida As
DEEPX HEALTH AS Board members of DEEPX HEALTH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Horn | Chief Executive Officer | 0 companies |
| Filip Truyen | Chairman | 0 companies |
| Hans Johan Hekland | Board of Directors | 0 companies |
| Frank Eithun Helland | Board of Directors | 0 companies |
| Øivind Enger | Board of Directors | 0 companies |